Jeffrey D Kelly

Director Jeffrey D Kelly sold 7,000 PGR shares at $216.33; post-transaction holdings 22,546 shares; -18.7% from 52-week high

Jeffrey D Kelly sold 7,000 shares (22.5K shares) of Progressive at $216.33 on 2026-06-24, reducing his stake by 23.7% to 22,546 shares. The sale occurred at a price 18.7% below the 52-week high of $267.92, though the stock has gained 9.6% over both the 30-day and 90-day periods. His prior two sales at PGR both resulted in positive returns over 90 days (10.5% and 12.0%), suggesting a pattern where the stock has risen after his previous sales at this ticker. With PGR trading at an 11.01 P/E and posting 16.3% annual revenue growth on $22.2B in quarterly revenue, the company shows fundamental strength, making the timing and magnitude of this director-level sale the primary investor consideration.

Director Jeffrey D Kelly sold 10,000 PGR shares at $250.00 for $2,500,000; post-transaction holdings 27,741 shares (-26.5%)

Director Jeffrey D Kelly sold 10,000 shares of Progressive at $250.00 on 2025-01-29, reducing his holdings by 26.5% to 27,741 shares. The sale price of $250.00 is modestly below the current price of $249.22 and sits within the 52-week range of $177.76–$268.88, at 7.3% below the 52-week high. In his cross-ticker track record, prior sells recorded an average 90-day return of 12.0% and a 90-day well-timed rate of 0.00%, indicating his past sales did not precede stock declines; his single prior PGR sale in October 2023 similarly generated positive 90-day returns (+12.0%), suggesting a pattern of selling before rallies rather than declines. The company reports strong fundamentals: $19.7B in latest-quarter revenue, $2.3B net income, and 25.2% annual revenue growth, with a P/E of 17.99 and market cap of $146.0B. The transaction represents a material but not dominant stake reduction in a large-cap, fundamentally sound insurer, with no evidence from timing patterns that this sale anticipates near-term adverse stock performance.